<DOC>
	<DOCNO>NCT00828971</DOCNO>
	<brief_summary>The purpose study assess therapy intravenous oral moxifloxacin effective therapy intravenous oral amoxicilline/clavulanate treatment complicate skin skin structure infection .</brief_summary>
	<brief_title>A Study Assess Efficacy Safety IV/PO Moxifloxacin Treatment cSSSIs</brief_title>
	<detailed_description />
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Written inform consent Men woman age &gt; /= 18 year diagnosis bacterial skin skin structure infection require Hospitalization Initial parenteral therapy least 48 hour Complicated least one follow criterion : Involvement deep soft tissue ( e.g . fascial , muscle layer ) Requirement significant surgical intervention include surgical drainage , drainage procedure guide image and/or debridement Association significant underlying disease may complicate response treatment . Presence SIRS ( Systemic Inflammatory Response Syndrome ) define two follow sign symptom : temperature &gt; 38.3°C &lt; 36°C white blood cell count &gt; 12.000/mmc &lt; 4.000 &gt; 10 % band pulse rate &gt; 90 beats/min respiratory rate &gt; 20178 systolic blood pressure &lt; /= 90 mmgHg decrease capillary refill/mottling &gt; 2 second lactate &gt; 2 mmol/L alter mental status hyperglycemia &gt; 120 mg/dl 7.7 mmol/L absence diabetes protein C ( CPR ) &gt; 20 mg/L ( VR 05 ) 3 . Duration infection &lt; 21 day Diagnosis one follow skin skin structure infection : major abscess ( e ) associate extensive cellulitis erysipelas cellulitis infected pressure ulcer ( ) wound infection include : post surgical ( surgical incision ) , post traumatic , human bite/clenched fist animal bite wound wound associate injection drug abuse Infected ischemic ulcer least one follow condition : Diabetes mellitus Peripheral vascular disease Conditions predisposing pressure score paraplegia peripheral neuropathy Presence least 3 follow local sign symptom purulent drainage discharge erythema extend &gt; 1 cm wound edge fluctuance pain tenderness palpation swell induration fever define body temperature &gt; 37.5°C ( axillary ) , &gt; 38°C ( orally ) , &gt; 38.5°C ( tympanically ) , &gt; 39°C ( rectally ) . OR Elevated total peripheral white blood cell ( WBC ) count &gt; 12,000/mm3 OR &gt; 15 % immature neutrophil ( blend ) regardless total peripheral WBC count Creactive protein ( CRP ) &gt; 20 mg/L Women , pregnant lactating , pregnancy exclude ( Note : urine pregnancy test perform woman childbearing potential randomization study drug ) . The following skin skin structure infection : Necrotizing fasciitis include Fournier 's gangrene , ecthyma gangrenosum , streptococcal necrotizing fasciitis clostridial necrotizing fasciitis . Burn wound infection . Secondary infection chronic skin disease ( eg , atopic dermatitis ) . Infection prosthetic material . Subjects removal prosthetic device involve infection include . Infections surgical procedure alone definitive therapy . Subjects uncomplicated skin skin structure infection include</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Complicated skin skin structure infection</keyword>
	<keyword>cSSSI</keyword>
</DOC>